Navigation Links
Targanta Study Shows Oritavancin Treatment Effective in a Mouse,Model of Anthrax

deaths and 125,000 hospitalizations.

About Oritavancin

Oritavancin, Targanta's lead product candidate, is a semi-synthetic lipoglycopeptide antibiotic with rapid in vitro bactericidal activity against a broad spectrum of serious gram-positive pathogens, including multi-resistant strains. Oritavancin's multiple targets and mechanisms of action work against the development of resistant strains, which is important when treating serious gram-positive infections. To date, over 1500 individuals have received oritavancin in clinical trials, including two large multi-national Phase 3 studies in complicated skin and skin structure infections (cSSSI) performed by former developers Eli Lilly and Company and InterMune, Inc. Targanta expects to file a New Drug Application (NDA) for oritavancin for the treatment of cSSSI with the U.S. Food and Drug Administration in the first quarter of 2008.

About Targanta Therapeutics Corporation

Targanta Therapeutics Corporation is a privately held biopharmaceutical company developing and commercializing innovative antibiotics to treat serious infections (either treated or acquired) in the hospital and other institutional settings. Its pipeline includes a number of antibacterial agents in various stages of development. The company has operations in Cambridge, MA, Indianapolis, IN, Montreal, Quebec, and Toronto, Ontario, Canada. For further information about Targanta, visit the company website, http://www.targanta.com.

About U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)

USAMRIID, located at Fort Detrick, Maryland, is the lead medical research laboratory for the U.S. Biological Defense Research Program, and plays a key role in national defense and in infectious disease research. The Institute's mission is to conduct basic and applied research on biological threats resulting in medical solutions (such as vaccines, drugs and d
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Targanta Reports Improved Ability of Oritavancin to Stop Bacteria Growth In Vitro Compared With Other Glycopeptide Antibiotics
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
4. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
11. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
Post Your Comments:
(Date:7/31/2014)... , July 31, 2014 Marken announced today ... facilities to meet the clinical trial logistics growth in ... newly expanded facility will continue to serve as a ... to and from the region, and will provide additional ... Marken will combine its office and warehouse into a ...
(Date:7/31/2014)... 2014 De Pfizer Clinical Research Unit (PCRU) ... vrijwilligers van Japanse komaf voor medewerking aan klinisch onderzoek. ... is één van twee onderzoekseenheden van Pfizer , ... verbeteren door de ontdekking en ontwikkeling van nieuwe medicijnen. ... naar mannen en vrouwen van Japanse komaf – leeftijd ...
(Date:7/30/2014)... , July 30, 2014  Cepheid (Nasdaq: ... purchasing contract with Premier will end on September ... GPO will be able to continue their relationship ... HPA, MedAssets, Novation, and ROi, in addition to ... with Cepheid. "Cepheid has always recognized ...
Breaking Medicine Technology:Marken Expands Miami Regional Logistics Center 2Gezonde vrijwilligers van Japanse komaf gezocht voor deelname aan Fase I klinisch onderzoek 2Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement 2Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement 3
(Date:7/31/2014)... According to a report by Fox ... knee replacement surgery on his left knee. This follows partial ... The story also reports that Bush was able to ride ... back on the bike again soon. This high level of ... knee replacement. , “Partial knee replacements give patients the ...
(Date:7/31/2014)... Hills, NY (PRWEB) July 31, 2014 ... Kim as its new board-certified plastic surgeon! , ... with helping men and women achieve the look of ... through his top procedures: breast augmentation (including ... breast or buttocks (also known as Brazilian butt lift), ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 The shale ... to the top of current U.S. natural gas production ... a “boom and bust” cycle, similar to previous resource ... study released today by Washington & Jefferson College’s (W&J) ... Environmental Law Institute (ELI) confirms that the gas boom ...
(Date:7/31/2014)... Some pain relief medications can be as addictive as ... day, 46 people in the U.S. die from legal pain ... admitted to an emergency room because of opioid complications. ... of prescription and over-the-counter painkillers and is calling on the ... make these drugs safer. , The full report, “Deadly Pain ...
(Date:7/31/2014)... CA (PRWEB) July 31, 2014 Staying happy ... be tricky at best. Men and women get sucked into ... wives, life partners, and taxi services to kids. , ... offers her "3 Fast + Fun Ways to Reignite the ... download . , “This is a much better path ...
Breaking Medicine News(10 mins):Health News:George W. Bush’s Surgery Highlights the Benefits of Partial Knee Replacement 2Health News:Bellava MedAesthetics Welcomes Dr. Chang Soo Kim as Its New Westchester Plastic Surgeon 2Health News:Pennsylvania’s Shale Gas: Examining the Boom and Bust Cycle 2Health News:Pennsylvania’s Shale Gas: Examining the Boom and Bust Cycle 3Health News:Consumer Reports Warns Against the Risks of Prescription and Over-The-Counter Painkillers 2Health News:Consumer Reports Warns Against the Risks of Prescription and Over-The-Counter Painkillers 3Health News:Couples in Trouble Relationship Expert, Dr. Jackie Black, Offers a Gift Guide to Reignite the Spark So Lovers Can Kiss-And-Make-Up 2Health News:Couples in Trouble Relationship Expert, Dr. Jackie Black, Offers a Gift Guide to Reignite the Spark So Lovers Can Kiss-And-Make-Up 3
... University of Leicester have opened up a whole new ... anti-cancer drug targets, thanks to a completely new and ... Watson, Fairall and Santos, have published their research this ... a new understanding of how transcriptional repression complexes work. ...
... at Oregon State University provides evidence for the first time ... in many animals can clearly cause accelerated neurodegeneration, loss ... published in Neurobiology of Disease and done by ... to this, it wasn,t clear which came first - whether ...
... 10 (HealthDay News) -- A drug commonly used to treat ... for people older than 40 years who have Down syndrome ... Although previous animal studies of the Alzheimer,s drug, memantine, showed ... of people with Down syndrome aged 40 and older revealed ...
... (AKI) has severe consequences, with a 25 to 80 percent ... diagnose AKI using a urine test, enabling emergency departments to ... hospital. The study will be published online on January 9, ... Cardiology. Physicians typically measure a patient,s creatinine levels ...
... risk of suffering a heart attack increases by approximately 21 ... one, according to a study lead by researchers at Beth ... 9 online in the journal Circulation found the ... the first week after the death of a loved one, ...
... Maureen Salamon HealthDay Reporter , MONDAY, Jan. 9 ... migraine patients as three types of traditional acupuncture, a new ... four groups at nine Chinese hospitals -- one sham acupuncture ... of researchers, including Dr. Fan-rong Liang at Chengdu University in ...
Cached Medicine News:Health News:Unexpected discovery opens up new opportunities for targeting cancer 2Health News:Disruption of biological clocks causes neurodegeneration, early death 2Health News:Alzheimer's Med Seems Ineffective in Those With Down Syndrome 2Health News:Biomarkers identify acute kidney injury in emergency patients 2Health News:Heart attack risk rises after loss of loved one 2Health News:Power of Acupuncture to Ease Migraines Questioned in Study 2Health News:Power of Acupuncture to Ease Migraines Questioned in Study 3
... The primary objective of the BioPro Toe ... that will relieve pain and restore motion ... foot undisturbed. The procedure used to implant ... bone resection. , ,The design for the ...
... Electrodes provide direct cranial nerve monitoring ... circumferential design provides sensitive contact on ... real-time recordings. This unique approach provides ... removal of acoustic neuromas, microvascular decompressions, ...
... Ad-Techs Intraoperative Electrodes share similar ... The main difference is that ... are numbered to assist you ... are designed for use with ...
... As with all of Ad-Techs products, our Sphenoidal ... quality. They are available in stainless steel or ... or 2.75 inch (70 mm) long, 21 gauge ... electrodes are supplied as kits or sets. You ...
Medicine Products: